The FDA has taken its first step toward reversing its 2023 stance, removing 12 peptides from the Category 2 do not compound list, including BPC-157, TB-500, GHK-Cu, MK-677, and more
Call your healthcare provider if you have symptoms, such as pain in your upper stomach (abdomen), fever, yellowing of the skin or eyes (jaundice), or clay- colored stools
Diabetes 2025;74(Supplement_1):1966-LB Consultado el 28 de enero de 2026: FDA approves Lilly's Foundayo (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions
Abstract As global life expectancy increases, research reveals a critical challenge in aging: the progressive deterioration of immune function, termed immunosenescence
GLP-1 Drugs Make Their First Move Around the Super Bowl For the first time, GLP-1 weight-loss medications are marketing around the Super Bowl, one of the years biggest cultural and media moments
Formulated with Glutathione that helps offer antioxidant and skin brightening effects, powered by ultra-small exosome technology for fast absorption and targeted care of deep dark spots
